Dornase
Last Updated: 02/24/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 431 publications
Transitioning Paediatric Empyema Management: Comparative Efficacy Analysis of tPA and DNase versus Surgical Interventions.
Journal: Journal of pediatric surgery
Published: October 18, 2025
Therapeutic potential of a long-acting form of rhDNase I for the treatment of cystic fibrosis.
Journal: International journal of biological macromolecules
Published: October 16, 2025
The impact of dornase alfa on imaging features of bronchiectasis.
Journal: Research square
Published: September 15, 2025
Elexacaftor/tezacaftor/ivacaftor is associated with long-term reduction in use of chronic respiratory therapies in cystic fibrosis.
Journal: Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society
Published: August 01, 2025
Pharmaceutical Compatibility of Tissue Plasminogen Activator and DNase.
Journal: Respiration; international review of thoracic diseases
Published: July 25, 2025
Pharmaceutical Compatibility of Tissue Plasminogen Activator and DNase.
Journal: Respiration; international review of thoracic diseases
Published: July 25, 2025
Preclinical Safety.
Journal: Journal of aerosol medicine and pulmonary drug delivery
Published: May 30, 2025
Persistent Atelectasis Prevalence and Incidence in Pediatric Critical Care.
Journal: Cureus
Published: May 11, 2025
Last Updated: 02/24/2026